151 related articles for article (PubMed ID: 28025923)
1. Progression to Uncontrolled Severe Asthma: A Novel Risk Equation.
Casciano J; Krishnan J; Small MB; Li C; Dotiwala Z; Martin BC
J Manag Care Spec Pharm; 2017 Jan; 23(1):44-50. PubMed ID: 28025923
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Economic Burden of Elevated Blood Eosinophils in Patients With and Without Uncontrolled Asthma.
Casciano J; Krishnan J; Dotiwala Z; Li C; Sun SX
J Manag Care Spec Pharm; 2017 Jan; 23(1):85-91. PubMed ID: 28025926
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study.
Price DB; Rigazio A; Campbell JD; Bleecker ER; Corrigan CJ; Thomas M; Wenzel SE; Wilson AM; Small MB; Gopalan G; Ashton VL; Burden A; Hillyer EV; Kerkhof M; Pavord ID
Lancet Respir Med; 2015 Nov; 3(11):849-58. PubMed ID: 26493938
[TBL] [Abstract][Full Text] [Related]
5. Value of peripheral blood eosinophil markers to predict severity of asthma.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
[TBL] [Abstract][Full Text] [Related]
6. Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
Bernstein JA; Virchow JC; Murphy K; Maspero JF; Jacobs J; Adir Y; Humbert M; Castro M; Marsteller DA; McElhattan J; Hickey L; Garin M; Vanlandingham R; Brusselle G
Lancet Respir Med; 2020 May; 8(5):461-474. PubMed ID: 32066536
[TBL] [Abstract][Full Text] [Related]
7. Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
Jackson DJ; Humbert M; Hirsch I; Newbold P; Garcia Gil E
Adv Ther; 2020 Feb; 37(2):718-729. PubMed ID: 31836949
[TBL] [Abstract][Full Text] [Related]
8. Burden of asthma with elevated blood eosinophil levels.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):100. PubMed ID: 27412347
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
[TBL] [Abstract][Full Text] [Related]
10. Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States.
Chase MR; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
J Manag Care Spec Pharm; 2016 Jun; 22(6):667-75. PubMed ID: 27231794
[TBL] [Abstract][Full Text] [Related]
11. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
[TBL] [Abstract][Full Text] [Related]
12. Burden of Alcohol Abuse or Dependence Among Long-Term Opioid Users with Chronic Noncancer Pain.
Landsman-Blumberg PB; Katz N; Gajria K; Coutinho AD; Yeung PP; White R
J Manag Care Spec Pharm; 2017 Jul; 23(7):718-724. PubMed ID: 28650247
[TBL] [Abstract][Full Text] [Related]
13. Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study.
Zeiger RS; Schatz M; Dalal AA; Chen W; Sadikova E; Suruki RY; Kawatkar AA; Qian L
J Allergy Clin Immunol Pract; 2017; 5(1):144-153.e8. PubMed ID: 27665383
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of the European Thoracic Society/American Thoracic Society severe asthma definition as a determinant of future use of biologics/bronchial thermoplasty.
Nishiyama H; Kanemitsu Y; Fukumitsu K; Takeda N; Kurokawa R; Tajiri T; Ito K; Yap JMG; Fukuda S; Uemura T; Ohkubo H; Maeno K; Ito Y; Oguri T; Takemura M; Niimi A
Asia Pac Allergy; 2022 Apr; 12(2):e13. PubMed ID: 35571548
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
16. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
Bellows BK; Olsen CJ; Voelker J; Wander C
J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
[TBL] [Abstract][Full Text] [Related]
17. Economic Impact of Above-Label Dosing with Etanercept, Adalimumab, or Ustekinumab in Patients with Psoriasis.
Feldman SR; Zhao Y; Zhou H; Herrera V; Tian H; Li Y
J Manag Care Spec Pharm; 2017 May; 23(5):583-589. PubMed ID: 28448778
[TBL] [Abstract][Full Text] [Related]
18. Effect of clinically significant thresholds of eosinophil elevation on health care resource use in asthma.
Dotiwala Z; Casciano J; Davis JR; Fox K; Gopalan G; Rastogi S; Lamerato L; Mathur SK
Ann Allergy Asthma Immunol; 2020 Aug; 125(2):182-189. PubMed ID: 32371242
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
[TBL] [Abstract][Full Text] [Related]
20. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
